Provided by Tiger Trade Technology Pte. Ltd.

Ironwood Pharmaceuticals

3.42
-0.2400-6.56%
Post-market: 3.430.0100+0.29%19:59 EST
Volume:4.63M
Turnover:15.57M
Market Cap:556.36M
PE:22.80
High:3.56
Open:3.55
Low:3.22
Close:3.66
52wk High:5.78
52wk Low:0.5271
Shares:162.68M
Float Shares:118.09M
Volume Ratio:0.74
T/O Rate:3.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1500
EPS(LYR):0.1500
ROE:-574.72%
ROA:19.88%
PB:-2.12
PE(LYR):22.80

Loading ...

Ironwood Pharmaceuticals Shares Jump 27.6% After Q3 Revenue Beat, Outlook Raise

THOMSON REUTERS
·
Nov 10, 2025

Ironwood Pharmaceuticals Q3 Revenue USD 122.06 Million

Reuters
·
Nov 10, 2025

Ironwood Pharmaceuticals reports third quarter 2025 revenue of $122.1 million

Reuters
·
Nov 10, 2025

Ironwood Pharmaceuticals Q3 Basic EPS USD 0.25

THOMSON REUTERS
·
Nov 10, 2025

Ironwood Pharmaceuticals: Engaged in Settlement Negotiations With Ferring Related to Complaint

THOMSON REUTERS
·
Nov 10, 2025

Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

THOMSON REUTERS
·
Nov 10, 2025

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Ironwood Pharma (IRWD)

TIPRANKS
·
Nov 07, 2025

BRIEF-FDA Approves Linzess Capsules For Children Aged 7 And Older With IBS With Constipation

Reuters
·
Nov 06, 2025

AbbVie, Ironwood Win FDA Approval for Linzess to Treat Children With Irritable Bowel Syndrome With Constipation

MT Newswires Live
·
Nov 06, 2025

FDA: Linzess Recommended Dosage for Pediatric Patients 7 Years and Older With Ibs-C Is 145 Mcg Orally Once Daily

THOMSON REUTERS
·
Nov 06, 2025

FDA: Approved Linzess (Linaclotide) Capsules for Pediatric Patients 7 Years and Older With Irritable Bowel Syndrome With Constipation

THOMSON REUTERS
·
Nov 06, 2025

Ironwood Pharmaceuticals Inc expected to post earnings of 10 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

Craig-Hallum Sticks to Its Hold Rating for Ironwood Pharma (IRWD)

TIPRANKS
·
Oct 29, 2025

Andrew Dreyfus to resign from Ironwood Pharmaceuticals Board following new CEO appointment at NIHCM Foundation

Reuters
·
Oct 10, 2025